Skip to content
Recall Observatory FDA recall evidence

Drug product

Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-467-99.

D-1328-2015

March 18, 2015

Class I

Product summary

Firm
Mylan Institutional LLC
Event
Event 70936
Status
Terminated
Classification
Class I
Quantity
a) 15,095 vials b) 300 vials
Official record key
drug-enforcement:D-1328-2015

Official wording

Reason: Presence of Particulate Matter

Code information: Lot #: a) 7801082, Exp. 07/15 and b) 7801421, Exp. 09/16

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter